Mohamad E. Allaf

Also affiliated with Johns Hopkins Medicine, Johns Hopkins Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial”.

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02284-w

N/A

3.0DataRank · unranked

106 citations

Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim +19 more

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00211-0

N/A

1.9DataRank · unranked

86 citations

Se-Eun Kim, Viraj A. Master, David H. McDermott, Lauren C. Harshman, Suzanne Cole +40 more

Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications

BMJ Open(2023)10.1136/bmjopen-2022-071191

N/A

0.925DataRank · unranked

15 citations

Alec Zhu, Andrew J. Vickers, Mohamad E. Allaf, Behfar Ehdaie, Anthony J. Schaeffer +15 more

PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5101

N/A

0.330DataRank · unranked

8 citations

Mäneka Puligandla, Mohamad E. Allaf, David F. McDermott, Charles G. Drake, Sabina Signoretti +15 more

Systematic Elucidation and Pharmacological Targeting of Tumor-Infiltrating Regulatory T Cell Master Regulators

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.22.481404

N/A

0.292DataRank · unranked

6 citations

Casey R. Ager, Mikko Turunen, Thomas R. Nirschl, Mohsen Khosravi‐Maharlooei, Christopher M. Jackson +10 more

Core biopsy (bx) accuracy and safety of biopsy and preoperative immunotherapy in predicting histological subtype and nuclear grade in ECOG-ACRIN EA8143 perioperative nivolumab (nivo) versus observation in patients (pts) with renal cell carcinoma (RCC) undergoing nephrectomy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4541

N/A

0.104DataRank · unranked

1 citations

Se Eun Kim, David F. McDermott, Viraj A. Master, Sabina Signoretti, Mahmut Akgül +13 more

PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4596

N/A

0DataRank · unranked

10 citations

Se Eun Kim, Viraj A. Master, David F. McDermott, Sabina Signoretti, David Cella +15 more

Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators

Cancer Cell(2023)10.1016/j.ccell.2023.04.003

N/A

0DataRank · unranked

58 citations

Casey R. Ager, Mikko Turunen, Thomas R. Nirschl, Mohsen Khosravi‐Maharlooei, Alina C. Iuga +16 more

Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial

European Urology(2024)10.1016/j.eururo.2023.12.015

N/A

0DataRank · unranked

181 citations

Melissa Assel, Mohamad E. Allaf, Behfar Ehdaie, Andrew J. Vickers, Andrew J. Cohen +19 more

T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3372

N/A

0DataRank · unranked

117 citations

Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross +14 more

Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance

British Journal of Urology(2025)10.1111/bju.16651

N/A

0DataRank · unranked

6 citations

Michael E. Rezaee, Roy Elias, Tina Wlajnitz, Sean A. Fletcher, Joseph Cheaib +8 more

Novel PET imaging methods for prostate cancer

World Journal of Urology(2020)10.1007/s00345-020-03344-3

N/A

0DataRank · unranked

19 citations

Peter Black, Soroush Rais‐Bahrami, Michael A. Gorin, Mohamad E. Allaf, Peter L. Choyke +1 more

PD02-10 THE IMPACT OF SURGEON AND HOSPITAL VOLUME ON 30-DAY OUTCOMES AND COST FOR RENAL CANCER SURGERY

The Journal of Urology(2020)10.1097/ju.0000000000000822.010

N/A

0DataRank · unranked

0 citations

Joseph Cheaib, Hiten D. Patel, Mitchell M. Huang, Michael J. Biles, Michael H. Johnson +4 more

A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis

European Urology(2021)10.1016/j.eururo.2021.11.002

N/A

0DataRank · unranked

33 citations

Roman Gulati, Michael A.S. Jewett, Kamel Fadaak, Antonio Finelli, Laura Legere +13 more

Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002642

N/A

0DataRank · unranked

19 citations

Jiajia Zhang, Boyang Zhang, Genevieve J. Kaunitz, Poromendro Burman, Hok-Yee Chan +8 more

Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111In]In‐XYIMSR‐01 for phase I regulatory approval

Journal of Labelled Compounds and Radiopharmaceuticals(2021)10.1002/jlcr.3906

N/A

0DataRank · unranked

4 citations

Michael A. Gorin, Ronnie C. Mease, Il Minn, Ala Lisok, Donika Plyku +7 more